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The prevalence of dental implants and related factors in patients with Sjögren’s 
syndrome: results from a cohort study  
Katinka Albrecht, Johanna Callhoff, Gisela Westhoff†, Thomas Dietrich, Thomas 
Dörner, Angela Zink 
Abstract  
Objective: To investigate prevalence and patient-reported outcomes of dental 
implants in patients with Sjögren’s syndrome (SS).  
Methods: A total of 205 female patients from an observational cohort study 
answered oral health questionnaires about periodontal signs and symptoms, 
dentures, dental implants, comorbidities and therapies that may interfere with bone 
remodeling. Data were compared with the reports of 87 female healthy controls.  
Results: The patients were younger than the controls (58 ±12 and 54 ±14 years, 
respectively) and differed substantially in the prevalence of self-reported gingivitis (46 
and 21%), self-reported periodontitis (19 and 8%) and in the numbers of remaining 
teeth (21 ±7 and 24 ±5 teeth). Patients more frequently had removable prostheses 
(30% compared to 21%) and dental implants (16% compared to 7%). The 32 SS 
patients with dental implants had a mean number of 3.3 ±2.0 implants. Notably, for 
patients with implants, their oldest existing implant survived for a mean period of 4.9 
±5.4 years. A total of 5 of 104 (4.8%) implants in the patients and none of the 14 
implants in the controls had to be removed. A total of 75% of the patients were highly 
satisfied with the implants and 97% would recommend them to other SS patients.  
Conclusion: A substantial portion of patients with SS have dental complications and 
require subsequent implants. The majority were satisfied with the implants and would 
recommend them to other patients. The high implant survival rate may encourage 
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patients, rheumatologists and dentists to consider dental implants for the treatment of 
SS patients. 
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Primary and secondary Sjögren's syndromes (SS) are systemic disorders 
characterized by lymphocyte infiltration and progressive destruction of exocrine 
glands leading to mucosal dryness, particularly of the eyes and mouth. The disease 
not only decreases saliva production but also alters the protein profile and the 
composition of saliva. Saliva has an active protective role in maintaining oral health 
under normal conditions (1). Saliva preserves the oral cavity through its lubricating 
function, which protects the soft tissues from desiccation, penetration or ulceration (1-
4). It also stimulates soft tissue repair by reducing clotting time and accelerating 
wound contraction. Furthermore, it contains numerous antibacterial, antiviral and 
antifungal agents which modulate the oral microbial flora (3-5).  
Because of its proteins, glycoproteins, enzymes, electrolytes, and small organic 
molecules, saliva preserves oral homeostasis and promotes the remineralization of 
teeth (5;6). The disturbance of this homeostasis in patients with SS results in an 
increased risk of dental caries and tooth loss (6-8). Due to this susceptibility, patients 
with SS frequently require dentures early in their lives. However, these patients are 
confronted with extraordinary difficulties when wearing removable dentures because 
mucosal dryness increases the risk of soreness in denture-bearing tissues, reduced 
retention of dentures and other complications, such as local candida infections. 
Implant-supported prostheses may offer a solution to ameliorate several of these 
prosthodontic complications in patients with SS. However, systemic conditions, such 
as rheumatoid arthritis, osteoporosis, diabetes mellitus or hyperthyroidism, as well as 
immunosuppressive therapies, have been regarded as risk factors for 
osseointegration, although the degree of systemic disease-‘control’ may be more 
important than the disorder itself (9). In many of these patients, quality of life and 
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functional benefits from dental implants may outweigh the risks (9). In a literature 
review focusing on implant survival in subjects diagnosed with systemic diseases that 
are regarded as possible contraindications, only case series were reported that 
compared patients with and without the condition in controlled settings (10;11). A 
recent cohort study and several case reports and case series on dental implants in 
patients with SS already indicate the feasibility of implant therapy for SS patients (11-
16).  
The aim of the present study was to evaluate the prevalence of dental implants in a 
large sample of patients with SS and to gauge the patients’ experience with dental 
implant therapy compared with healthy control subjects.  
 
Methods 
The data of females with SS from an observational prospective cohort study in 
Germany were used. Enrolment with annual follow-up was initiated in 2009 in four 
specialized rheumatologic centers in Germany that were participating in a 
collaborative project promoted by the European League Against Rheumatism 
(EULAR) to develop consensus disease activity indices (17). Patients were 
diagnosed with primary or secondary SS according to the European American 
Consensus Group criteria (18). Controls were patients’ female friends of 
approximately the same age (±3 years) who were not suffering from dry eyes or dry 
mouth. Details regarding recruitment and annual follow-ups have been described 
elsewhere (17).  
All patients enrolled in the cohort until February 2012 were asked to complete an oral 
health questionnaire to ascertain oral problems and provision with dental prostheses. 
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The questionnaire assessed previous and current dental and periodontal signs and 
symptoms, such as toothache, caries, bleeding of the gums, gingivitis and 
periodontitis; these assessments were further categorized in relation to time (since 
childhood, adolescence or adulthood) and frequency (not at 
all/once/sometimes/frequently during the past 12 months/no more or more frequently 
than others). The signs of gingivitis and periodontitis were explained and illustrated. 
The patients also reported the number of natural teeth present (all = 28, excluding 
wisdom teeth) and dental prostheses (crowns, bridges, removable prostheses and/or 
fixed implants) including the number of implants, for how long the oldest implant had 
been in place (in years), and whether any of their implants had been removed or 
replaced.  
Global health, oral dryness, satisfaction with dental implants and dental care in 
general were reported on numerical rating scales (NRS 0-10). Patients also reported 
their attitudes towards dental implants (in need of, interested in, or afraid of 
complications). Those with implants were asked whether they would recommend 
dental implants to other patients with SS (without hesitation, rather yes, rather no, not 
at all). All participants reported on comorbid conditions (osteoporosis, diabetes 
mellitus, hyperthyroidism and cancer) and medications (glucocorticoids, 
bisphosphonates, anticoagulants, anticonvulsives, and chemotherapy) that may 
interfere with bone remodeling. Ethical approval was obtained from the Charité 
University Medicine Berlin ethical review board in April 2009. All patients gave 
informed written consent to participate. 
Statistical analysis 
Descriptive analyses were performed to evaluate the number of patients with oral 
complaints, the number of teeth, their provision with dental prostheses and 
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satisfaction with dental care. Chi square statistics and Fisher’s exact test were used 
to determine differences in the categorical variables of patients and controls with and 
without dental implants. The independent sample t test was used for continuous 
measures.  
The association between demographic and clinical parameters and considerable 
tooth loss (≤20 teeth left) was examined using multivariable logistic regression 
analysis. Predictor variables were age (continuous), formal education (compulsory, 
secondary, or higher), smoking (never, past, or currently), body mass index (<20, 20-
<25, 25- <30, or ≥30), diabetes mellitus (yes/no), duration of oral dryness (≤10, 11 – 
20, or >20 years), severity of oral dryness (NRS 0 – 10), self-reported periodontitis 
(yes/no), frequent caries in adolescence (yes/no) and frequent bleeding of the gums 
in adolescence (yes/no). The model with three covariates and the best likelihood 
score was selected.  
In a multivariable logistic regression analysis, predictors of satisfaction with dental 
implants (lower versus high satisfaction: NRS ≥3 vs. <3) were analyzed, considering 
age, possible contraindications for implant therapy, such as osteoporosis, diabetes 
mellitus, cancer, hyperthyroidism, glucocorticoids, bisphosphonates, anticoagulants, 
anticonvulsants and chemotherapy (yes/no), as well as the oral parameters listed 
above as covariates.  
To verify whether patients with dental implants were selected for this treatment 
because of their low risk profile, patients with and without dental implants were 
compared using Chi square test and Fisher’s exact test as appropriate with regard to 





Patients and controls 
A total of 230 patients from the Sjögren cohort and 89 controls were asked to answer 
the dental questionnaire. The data from 205 patients and 87 controls were available 
for analysis. 25 patients did not answer the questionnaire. A total of 76% of patients 
were diagnosed with primary and 24% with secondary SS. The controls were aimed 
to have a comparable age as the patients but they ended to be on average four years 
younger than patients. They also had a higher educational level and were more 
frequently current smokers. They differed substantially in the prevalence of self-
reported toothache, self-reported periodontitis and the number of natural teeth. 
Patients were more likely to have removable prostheses and dental implants (Table 
1).  
Number of natural teeth 
Patients of higher age, with lower formal education, longstanding oral dryness and 
current severe oral dryness reported the lowest numbers of natural teeth. Tooth loss 
was furthermore associated with self-reported periodontitis, self-reported frequent 
caries and frequently bleeding gums in adolescence (Table 2). Smokers and adipose 
patients did not report fewer teeth than non-smokers or those with normal weight (not 
shown). Smoking was very rare (5.3%) in patients with multiple oral problems and 
predominantly reported by younger patients whose teeth remained. In addition, age, 
oral dryness and severe caries in adolescence were the best independent predictors 
of considerable tooth loss (≤20 teeth left; 34% of patients) in multivariable logistic 
regression analyses (≤20 vs. >20 teeth: adjusted odds ratio (OR) caries vs. no = 4.0, 
95% CI 1.8 to 8.5; P = <0.001 and oral dryness adjusted OR per unit 1.2, 95% CI 1.1 
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to 1.4). An alternative linear regression with the number of teeth as the continuous 
variable confirmed the results of the binary logistic regression in general.  
Dental implants  
More patients (16%) than controls (7%) had dental implants. Patients and controls 
with implants were older and had fewer remaining teeth than participants without 
dental implants (Table 3). These differences were statistically significant for SS 
patients only. In SS patients with dental implants, the mean age of the oldest existing 
implant was 4.9 years. Five of 104 implants in SS patients had to be removed. One of 
the five removed implants had been replaced.  
Comorbid conditions and therapies  
A total of 59% of the patients with dental implants reported taking at least one drug 
considered a risk factor for implant failure, whereas none of the controls with implants 
took any of these drugs. Hyperthyroidism and diabetes were equally frequent in 
patients with and without implants, whereas osteoporosis and the use of 
bisphosphonates were markedly higher in patients without implants (Table 4).  
Satisfaction with dental implants 
A total of 75% of the patients with dental implants were highly satisfied with their 
restorations (NRS 0-2), including three of five patients who had lost one implant 
each. The remaining patients indicated at least moderate satisfaction (NRS 3-5). The 
32 SS patients with implants reported similar satisfaction levels with their implants as 
the six control subjects with implants (patients vs. controls NRS 1.5 vs. 0.7; p = 0.21). 
A total of 21 of 32 patients (66%) would recommend dental implants without 
hesitation to other SS patients; 10 would rather recommend them, and only one 
9 
 
would rather not recommend them. Patients with implants indicated higher 
satisfaction with their overall dental care than patients without (NRS 1.8 ±1.6 vs. 3.7 
±2.9; p<0.001). The multivariable logistic regression analysis retrieved no predictors 
of moderate or poor satisfaction (NRS ≥3; n = 9). 
Attitudes towards dental implants  
Patients and controls without dental implants had similar attitudes towards artificial 
teeth. About half of both groups indicated no interest in this type of treatment, and 
approximately one fifth of both groups reported they were determined to obtain 
implants (Table 5). Beyond that, the two groups differed substantially. Patients 
indicated greater need for implants and greater concern about not being able to 
afford them. Patients were also more likely to rate their knowledge about dental 
implants as insufficient but were twice as likely to express their apprehension that 
implants could not integrate properly. Attitudes towards implants were only 
moderately associated with the number of teeth in both groups. Attitudes were not 
associated with the severity of oral dryness in the patients. A total of 87 patients and 
25 controls had already discussed implant therapy with their dentist and 9 patients 
had talked about implants with their rheumatologist. Of those, 33 patients and 5 
controls were advised against implants by their dentist, 1 patient was advised against 
implants by her rheumatologist and 1 patient by both. In 30 out of 33 patients who 
were advised against implants, dentists were concerned about initial osseointegration 
or a higher risk of implant failure. Only a minority of patients, regardless of implant 
status, knew that statutory health insurance grants full coverage of costs for dental 
implant therapy in patients with severe oral dryness since 2006 in Germany (with 
implants 28%, without implants 6%). Notably, only six patients had heard about the 
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indication from their dentist, and only ten patients had discussed dental implant 
therapy with their rheumatologist. 
Discussion  
In this large cohort of patients with SS, a considerable proportion had dental 
implants. Patients with SS had fewer teeth than controls, and tooth loss was 
associated with rheumatoid arthritis and also with self-reported periodontitis. The 
patients were in general highly satisfied with their dental implants, and all but one 
would recommend dental implants to other patients with SS.  
The substantial prevalence of dental implants and the patient perspectives of the 
present cohort show that dental implants are highly regarded by these patients. High 
satisfaction was also found in patients with additional comorbid conditions and 
therapies that interfere with the immune system.  
In a recent systematic review, an implant survival rate of 92% in SS patients is 
reported with a mean observation period of 48 months. However, the SS patient 
number was only 17 (19). Common implant therapy in SS patients (21%), a high 
implant survival (97%, with a medium follow up of 46 months) and a high patient 
satisfaction are also reported from a recent cohort study on 50 SS patients with 
dental implants and matched controls (16). Data from studies reporting on implant 
failure risks are heterogeneous, and the level of evidence regarding contraindications 
for implant therapy remains low (10;20-24). In the majority of cases in which an 
implant fails to integrate, the cause is unknown (19). Our findings from the present 
study suggest that SS itself does negatively affect the biology of osseointegration.  
A rather large number of dentists and rheumatologists advised the patients not to 
have dental implants. The majority of them had expressed concerns about initial 
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osseointegration or a higher risk of implant failure. In addition, we cannot rule out that 
other aspects such as the specific dental status of the included patients were 
responsible for implant therapy not being recommended. However, our data and 
those reported by Korfage et al. (16) suggest that dental implants should be 
considered by dentists and rheumatologists as a viable treatment option in patients 
with SS.  
Limitations and strengths 
The lack of data from a clinical dental examination is an important limitation as the 
condition of the peri-implant mucositis and peri-implantitis could not be evaluated. 
Furthermore, self-reported gingivitis and self-reported periodontitis has limited validity 
(25), and the associated results need to be interpreted with caution. It should be 
noted that prevalence of self-reported periodontitis in our study was much lower than 
that of clinically assessed moderate or severe periodontitis (46%) in a recent study of 
SS patients (26). The control group differs considerably in age, educational level and 
smoking, all of which may influence gum inflammation, periodontal and implant 
status. Furthermore, the number of subjects with implants and failed implants is too 
small to establish risk factors for implant loss. A risk rate for the loss of an implant 
could not be calculated because information on the time to implant loss or on the age 
of all remaining implants is missing. The patients only recorded the longest standing 
implant, which might obscure the implant survival rate. The strength of the study is 
the large sample size and the provision of patient-reported satisfaction with dental 
implants that should be equally considered for clinical outcomes.  
Our findings reported here are consistent with the study by Korfage et al. and 
encourage the consideration of implants in the dental treatment of SS patients (16). 
However, because of the limitations of a retrospective assessment of implant failure 
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and the limitation of patient self-reports, as well as the high need for dental implants 
in this group of patients, a prospective study that includes clinical and radiographic 
dental data is still required. 
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